Evidence map›Paper›PMID 16825297›Full record

ArticleThe Journal of physiology2006

Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.

Jie Wu, Qiang Liu, Kewei Yu, Jun Hu, Yen-Ping Kuo, Marsha Segerberg, Paul A St John, Ronald J Lukas

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Cocaine potently blocks neuronal αActa pharmacologica Sinica · 2020
    Article
  8. Article
  9. The relationship between nicotine and psychosis.Therapeutic advances in psychopharmacology · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jie WuNeurophysiology Laboratory, Division of Neurology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, AZ 85013-4496, USA. jie.wu@chw.edu
Qiang Liu
Kewei Yu
Jun Hu
Yen-Ping Kuo
Marsha Segerberg
Paul A St John
Ronald J Lukas
Barrow Neurological Institute · USChandler–Gilbert Community College · USUniversity of Arizona · US

Funding

Research Education ComponentP30AG019610 · NIA · SUN HEALTH RESEARCH INSTITUTE · PI GONZALEZ HERNANDEZ, GRACIELA · 2001 to 2020
$32.5M
Molecular Bases for Effects of NicotineR01DA015389 · NIDA · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI LUKAS, RONALD J · 2003 to 2007
$1.6M
NIA NIH HHS P30 AG019610NIA NIH HHS P30 AG19610NIDA NIH HHS DA015389NIDA NIH HHS R01 DA015389
6 · The paper itself

Abstract

Naturally expressed nicotinic acetylcholine receptors (nAChR) containing alpha4 subunits (alpha4*-nAChR) in combination with beta2 subunits (alpha4beta2-nAChR) are among the most abundant, high-affinity nicotine binding sites in the mammalian brain. beta4 subunits are also richly expressed and colocalize with alpha4 subunits in several brain regions implicated in behavioural responses to nicotine and nicotine dependence. Thus, alpha4beta4-nAChR also may exist and play important functional roles. In this study, properties were determined of human alpha4beta2- and alpha4beta4-nAChR heterologously expressed de novo in human SH-EP1 epithelial cells. Whole-cell currents mediated via human alpha4beta4-nAChR have approximately 4-fold higher amplitude than those mediated via human alpha4beta2-nAChR and exhibit much slower acute desensitization and functional rundown. Nicotinic agonists induce peak whole-cell current responses typically with higher functional potency at alpha4beta4-nAChR than at alpha4beta2-nAChR. Cytisine and lobeline serve as full agonists at alpha4beta4-nAChR but are only partial agonists at alpha4beta2-nAChR. However, nicotinic antagonists, except hexamethonium, have comparable affinities for functional alpha4beta2- and alpha4beta4-nAChR. Whole-cell current responses show stronger inward rectification for alpha4beta2-nAChR than for alpha4beta4-nAChR at a positive holding potential. Collectively, these findings demonstrate that human nAChR beta2 or beta4 subunits can combine with alpha4 subunits to generate two forms of alpha4*-nAChR with distinctive physiological and pharmacological features. Diversity in alpha4*-nAChR is of potential relevance to nervous system function, disease, and nicotine dependence.

Indexed as

AcetylcholineAlkaloidsAzocinesBridged Bicyclo Compounds, HeterocyclicCell LineElectrophysiologyEpithelial CellsHexamethoniumHumansLobelineNicotineNicotinic AgonistsNicotinic AntagonistsPatch-Clamp TechniquesPyridinesQuinolizidine AlkaloidsAcetylcholineAlkaloidsalpha(4)beta(4) nicotinic receptorAzocinesBridged Bicyclo Compounds, HeterocycliccytisineepibatidineHexamethoniumLobelineNicotineNicotinic AgonistsNicotinic Antagonistsnicotinic receptor alpha4beta2PyridinesQuinolizidine AlkaloidsQuinolizinesReceptors, Nicotinic

Identifiers

PMID16825297
PMCPMC1995635
OpenAlexW1530038052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.